Growth Metrics

Nuwellis (NUWE) Preferred Shares Issued (2016 - 2017)

Nuwellis posted quarterly Preferred Shares Issued of $184000.0 for Q1 2017, down 94.53% on a QoQ basis from $3.4 million in Q3 2016.

Nuwellis (NUWE) has 2 years of Preferred Shares Issued data on file, last reported at $184000.0 in Q1 2017.

  • For the quarter ending Q1 2017, Preferred Shares Issued changed N/A year-over-year to $184000.0; the trailing twelve-month figure through Mar 2018 stood at $184000.0 (changed N/A YoY), and the FY2024 full-year result was $501000.0, down 66.19% from the prior year.
  • Preferred Shares Issued for Q1 2017 stood at $184000.0, down from $3.4 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $3.4 million in Q3 2016 and bottomed at $184000.0 in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Nuwellis 1.45 Mn -630,292.49 1.68 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2017 184,000.00
Mar 31, 2017 184,000.00
Sep 30, 2016 3.36 Mn
Sep 30, 2016 3.36 Mn